Back |
home / stock / bbio / bbio message board
Subject | By | Source | When |
---|---|---|---|
#$BBIO ?? Price dropped 70% & since | da_stock_analyst | investorshub | 01/02/2022 10:52:44 PM |
Missed the big move again and shorted off | Pyramid2 | investorshub | 01/01/2022 7:45:34 PM |
Happy New Years World & $BBIO | 02opida | investorshub | 01/01/2022 4:03:39 PM |
Yea... I didn't see the huge day coming | Drugdoctor | investorshub | 12/31/2021 6:04:32 PM |
got more this am & Long 2022 | 02opida | investorshub | 12/31/2021 5:56:57 PM |
I sold $BBIO this morning... my bounce play | Drugdoctor | investorshub | 12/31/2021 2:45:35 PM |
BridgeBio Pharma, Inc. (BridgeBio) is a biopharmaceutical company | 02opida | investorshub | 12/30/2021 7:33:21 PM |
BridgeBio Pharma Reports Month 12 Topline Results from | 02opida | investorshub | 12/30/2021 7:32:49 PM |
Looking good & moving back up again $BBIO | 02opida | investorshub | 12/30/2021 7:31:54 PM |
Nice Consolidation on $14, missed the big move | Pyramid2 | investorshub | 12/30/2021 11:48:52 AM |
$BBIO-Analysts-NEW-PRICE-TARGETS are double current price after 71% decline | Drugdoctor | investorshub | 12/28/2021 12:43:43 PM |
https://www.tipranks.com/stocks/bbio/forecast All Analysts call the low @25 per | Cat dog | investorshub | 12/27/2021 8:35:51 PM |
Major reversal coming soon to a bank account | Steve0229 | investorshub | 12/27/2021 6:06:46 PM |
Buy Buy Buy @ 20 with ease !!!! | Cat dog | investorshub | 12/27/2021 4:46:48 PM |
In on this one today. Appears to | ok2buy | investorshub | 12/27/2021 3:16:02 PM |
Whats the story behind the massive options call | cchackal | investorshub | 11/30/2021 10:54:01 PM |
News, Short Squeeze, Breakout and More Instantly...
BridgeBio Pharma Inc. Company Name:
BBIO Stock Symbol:
NYSE Market:
- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and cardiovascular-related hospitalization (CVH) in ATTR-CM participants through m...
2024-05-28 07:00:15 ET Eliana Merle from UBS issued a price target of $47.00 for BBIO on 2024-05-28 05:24:00. The adjusted price target was set to $47.00. At the time of the announcement, BBIO was trading at $27.94. The overall price target consensus is at $32.25 with hi...
- BridgeBio to host investor call on Wednesday, May 29, 2024 at 5:30 pm ET, with presentations from Mathew Maurer, M.D. of Columbia University Irving Medical Center, U.S. and Ahmad Masri, M.D., M.S. of Oregon Health & Science University, U.S. PALO ALTO, Calif., May 24, 2024 (GLOBE NEW...